Gastrodomina 20 mg 20 Tablets

- Classification: Digestive system - Antacids - H2-receptor antagonist. - Indications: Esophageal reflux cases. Stomach hyperacidity. Stomach, peptic and duodenal ulcers with other antacid drugs. Erosive (ulcerative) esophagitis. Zollinger-Ellison syndrome. Increased secretion of stomach acids. Dyspepsia. It can also be used in children in gastroenteritis of various causes to reduce vomiting. Dosage : adults: Adult dosage for duodenal ulcer: Dosage of tablets: 40 mg once daily before bedtime or 20 mg twice daily Injection dose: 20 mg intravenously every 12 hours. Some doctors prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. The patient will continue to take 20 mg intravenously or as a tablet at bedtime, once daily. Adult dosage for peptic ulcer: Dosage of tablets: 40 mg once daily at bedtime or 20 mg twice daily Injection dose: 20 mg intravenously every 12 hours. Some physicians prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. The patient will continue to take 20 mg intravenously or as a tablet at bedtime, once daily. Adult dose for the prevention of duodenal ulcer: 20 mg intravenously or as a tablet at bedtime, once daily. Adult dosage for stomach ulcers: Dosage of tablets: 40 mg once daily at bedtime or 20 mg twice daily Injection dose: 20 mg intravenously every 12 hours. Some physicians prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. Adult dosage for GERD: Dosage of tablets: 20 mg orally twice daily for up to 6 weeks Injection dose: 20 mg intravenously every 12 hours. Some physicians prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. Adult dosage for erosive (ulcerative) esophagitis: Dosage of tablets: 20-40 mg orally twice daily for up to 12 weeks. Injection dose: 20 mg intravenously every 12 hours. Some physicians prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. Usual Adult Dose for Zollinger-Ellison Syndrome: Tablet dosage: Initial dose: 20 mg every 6 hours. The dose that the patient will continue to be adjusted to be able to control stomach acid secretions, doses of up to 160 mg every 6 hours have been used Injection dose: 20 mg intravenously every 6 hours. Some physicians prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. Usual Adult Dose for Hypersecretion of Gastric Acid: Tablet dosage: Initial dose: 20 mg every 6 hours. The dose that the patient will continue to be adjusted to be able to control stomach acid secretions, doses of up to 160 mg every 6 hours have been used Injection dose: 20 mg intravenously every 6 hours. Some physicians prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. Usual Adult Dose for Dyspepsia: 10 mg tablets once or twice daily Usual Adult Dose for Upper Gastrointestinal Bleeding: Injection dose: 20 mg intravenously every 12 hours. Some physicians prescribe 10 mg intravenously followed by slow continuous intravenous infusion at a dose of 3.2 mg every hour for 72 hours. Usual Adult Dose for Allergy: Dosage of 20 mg intramuscularly once children: Usual Junior Dose for Peptic Ulcer: ectoderm: Dosage for children 1 to 16 years of age: 0.5 mg per kg once daily at bedtime or divided into two doses during the day Maximum dose 40 mg daily Doses up to 1 mg per kg of body weight per day are used Stress ulcer, stomach acid reduction Injection dose: 0.5-1 mg per kg every 12 hours The maximum dose is 20 mg every 12 hours In cases of treatment of increased gastric acid secretion: Initial dose for adolescents as 20 mg tablets every 6 hours and may be increased to 160 mg every 6 hours Usual Pediatric Dose for GERD: Children 1-3 months: Dosage of tablets: 0.5 mg per kg once daily for up to 8 weeks. Children from 3 months to 1 year of age: Dosage of tablets: 0.5 mg per kg twice daily for up to 8 weeks. Children from 1 to 16 years old: The dose of the tablets is 0.5 mg per kg twice daily and the dose can be increased up to 1 mg per kg Maximum dose 40 mg For patients who cannot take the tablets, the medication can be taken by intravenous infusion. Intravenous doses: Infants: 0.25 - 0.5 mg per kg once daily Children 1 to 16 years of age: Initial dose 0.25 mg per kg every 12 hours (maximum dose 20 mg). Doses of up to 0.5 mg/kg every 12 hours have been used Usual Pediatric Dose for Dyspepsia: Children over 12 years: For the treatment of heartburn and stomach pain, 10-20 mg 15-60 minutes before eating, and the dose does not exceed two tablets per day. Dosage adjustment in renal disease: In moderate renal failure (creatinine clearance less than 50 mM) or severe kidney failure (creatinine clearance less than 10 mM), the dose should be halved or doses separated 36-48 hours. Dosage adjustment in hepatic disease: the dose does not need to be adjusted The presence of stomach cancer, especially in the elderly (over 50 years), should be excluded before starting famotidine treatment, as taking it may lead to a delay in diagnosis, and improvement of symptoms does not mean excluding the presence of a cancerous tumor. Continuation of treatment for a period of 6:8 weeks is usually sufficient to treat ulcers, and for the treatment of erosive esophagitis, the duration of treatment does not exceed 12 weeks. The group of H2 antagonists is not sufficient to treat upper gastrointestinal bleeding, and the US Food and Drug Administration has not authorized this use for them.